Finance

Lists
Why is 002399 up 2.50%?
Dive Deeper
002399:SHE
Shenzhen Hepalink Pharma Group Co Ltd
CN¥9.85
+2.50%
(+0.24) 1D
Sep 30, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002399...
Open
CN¥9.61
High
CN¥9.92
Low
CN¥9.56
Mkt. cap
13.05B
Avg. vol.
5.64M
Volume
4.15M
Dividend
1.47%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
71.23
52-wk high
CN¥12.68
52-wk low
CN¥8.50
EPS
CN¥0.14
Shares outstanding
1.25B
No. of employees
2K
Open
CN¥9.61
High
CN¥9.92
Low
CN¥9.56
Mkt. cap
13.05B
Avg. vol.
5.64M
Volume
4.15M
Dividend
1.47%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
71.23
52-wk high
CN¥12.68
52-wk low
CN¥8.50
EPS
CN¥0.14
Shares outstanding
1.25B
No. of employees
2K
News stories
From web sources and news partners
About Shenzhen Hepalink Pharma Group Co Ltd
CEO-
Employees2.1K
FoundedApr 21, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.38B
1.28B
1.33B
1.25B
Cost of goods sold
884.21M
900.40M
876.31M
826.48M
Cost of revenue
884.21M
900.40M
876.31M
826.48M
Research and development expenses
73.11M
50.33M
36.44M
45.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
216.50M
252.73M
209.31M
238.09M
Operating expense
291.36M
336.08M
263.62M
301.09M
Total operating expenses
1.18B
1.24B
1.14B
1.13B
Operating income
201.54M
48.03M
190.92M
121.10M
Other non operating income
182.67M
-254.18M
-122.99M
121.83M
EBT including unusual items
157.96M
-239.36M
207.68M
72.85M
EBT excluding unusual items
188.04M
-97.72M
93.38M
76.27M
Income tax expense
26.52M
-29.37M
20.31M
-14.68M
Effective tax rate
16.79%
12.27%
9.78%
-20.15%
Other operating expenses
6.60M
16.33M
8.11M
7.92M
Net income
131.73M
-204.09M
187.57M
87.71M
Net profit margin
9.57%
-15.89%
14.09%
7.02%
Earnings per share
-
-
-
-
Interest and investment income
33.52M
-
38.50M
1.33M
Interest expense
-15.15M
-32.17M
-13.05M
-12.63M
Net interest expenses
18.37M
-32.17M
25.45M
-11.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
271.82M
128.19M
271.08M
201.09M
Gain or loss from assets sale
1.29M
-1.84M
-
26.67K
AI content may include mistakes. Learn more
Google apps